5WHO/IUATLD.Guidelines for surveillance of drug resistance in tuberculosis.Int J Tuberc Lung Dis,1998,2:71-89.
6DeRiemer K,García-García L,Bobadilla-del-Valle M,et al.Does DOTS work in populations with drug-resistant tuberculosis? Lancet,2005,365:1239-1245.
7Durmaz R,Ozerol IH,Durmaz B,et al.Primary drug resistance and molecular epidemiology of Mycobacterium tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey.Microb Drug Resist,2003,9:361-366.
8Lambregts-van Weezenbeek CS,Jansen HM,Veen J,et al.Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands:the truth behind the rates.Int J Tuberc Lung Dis,1998,2:296-302.
9Seung KJ,Bai GH,Kim SJ,et al.The treatment of tuberculosis in south Korea.Int J Tuberc Lung Dis,2003,7:912-919.
10Center for Disease Control and Prevention.TB elimination:now is the time.2002.Available from:URL:http://www.cdcnpin.org/scripts/tb/eliminate.asp.
